Definitive Healthcare Corp (DH)vs10X Genomics Inc (TXG)
DH
Definitive Healthcare Corp
$0.71
+4.13%
HEALTHCARE · Cap: $72.31M
TXG
10X Genomics Inc
$52.03
+14.10%
HEALTHCARE · Cap: $6.00B
Smart Verdict
WallStSmart Research — data-driven comparison
10X Genomics Inc generates 168% more annual revenue ($638.78M vs $238.26M). TXG leads profitability with a -3.5% profit margin vs -71.5%. DH earns a higher WallStSmart Score of 37/100 (F).
DH
Hold37
out of 100
Grade: F
TXG
Avoid20
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+77.8%
Fair Value
$7.63
Current Price
$0.71
$6.92 discount
Margin of Safety
+68.1%
Fair Value
$60.02
Current Price
$52.03
$7.99 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
ROE of -116.5% — below average capital efficiency
Trading at 8.2x book value
0.0% earnings growth
Weak financial health signals
ROE of -2.8% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : DH
The strongest argument for DH centers on Price/Book.
Bull Case : TXG
The strongest argument for TXG centers on Debt/Equity.
Bear Case : DH
The primary concerns for DH are EPS Growth, Market Cap, Debt/Equity.
Bear Case : TXG
The primary concerns for TXG are Price/Book, EPS Growth, Piotroski F-Score.
Key Dynamics to Monitor
TXG carries more volatility with a beta of 2.04 — expect wider price swings.
TXG is growing revenue faster at -2.6% — sustainability is the question.
TXG generates stronger free cash flow (25M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DH scores higher overall (37/100 vs 20/100). TXG offers better value entry with a 68.1% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Definitive Healthcare Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Definitive Healthcare Corp (DH) is a leading provider of comprehensive data and analytics solutions designed specifically for the healthcare industry, catering to a diverse clientele that includes pharmaceutical companies, payers, and healthcare providers. By harnessing extensive datasets and cutting-edge real-time analytics, Definitive Healthcare enhances operational efficiencies and delivers critical strategic insights, ultimately improving patient outcomes. With a strong commitment to innovation, the company is well-positioned to capitalize on the growing demand for sophisticated healthcare analytics, thereby establishing itself as a pivotal player in the transformation of healthcare delivery.
Visit Website →10X Genomics Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and Asia Pacific. The company is headquartered in Pleasanton, California.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?